Vaughan Nelson Investment Management’s AbbVie ABBV Stock Holding History

Vaughan Nelson Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.17M	Hold	8,635	–	–	0.02%	160
2026 Q1	$1.88M	Sell	8,635 -125	-1%	-$27.7K	0.02%	160
2025 Q4	$2M	Sell	8,760 -12,375	-59%	-$2.82M	0.02%	158
2025 Q3	$4.89M	Hold	21,135	–	–	0.04%	142
2025 Q2	$3.92M	Hold	21,135	–	–	0.04%	140
2025 Q1	$4.43M	Hold	21,135	–	–	0.04%	147
2024 Q4	$3.76M	Hold	21,135	–	–	0.03%	142
2024 Q3	$4.17M	Buy	21,135 +60	+0.3%	+$11.2K	0.04%	141
2024 Q2	$3.62M	Hold	21,075	–	–	0.03%	145
2024 Q1	$3.84M	Sell	21,075 -27	-0.1%	-$4.65K	0.03%	145
2023 Q4	$3.27M	Sell	21,102 -2,973	-12%	-$433K	0.03%	157
2023 Q3	$3.59M	Buy	24,075 +165	+0.7%	+$24.2K	0.04%	165
2023 Q2	$3.22M	Sell	23,910 -2,015	-8%	-$295K	0.04%	162
2023 Q1	$4.13M	Sell	25,925 -9,000	-26%	-$1.38M	0.05%	145
2022 Q4	$5.64M	Buy	34,925 +750	+2%	+$115K	0.07%	150
2022 Q3	$4.59M	Hold	34,175	–	–	0.07%	139
2022 Q2	$5.23M	Hold	34,175	–	–	0.07%	144
2022 Q1	$5.54M	Hold	34,175	–	–	0.06%	146
2021 Q4	$4.63M	Sell	34,175 -1,327	-4%	-$157K	0.05%	145
2021 Q3	$3.83M	Buy	35,502 +4,477	+14%	+$512K	0.04%	147
2021 Q2	$3.5M	Buy	31,025 +2,625	+9%	+$296K	0.04%	147
2021 Q1	$3.07M	Buy	28,400 +4,250	+18%	+$455K	0.03%	141
2020 Q4	$2.59M	Buy	24,150 +12,400	+106%	+$1.19M	0.03%	145
2020 Q3	$1.03M	Sell	11,750 -672,620	-98%	-$63.3M	0.01%	167
2020 Q2	$67.2M	Sell	684,370 -20,695	-3%	-$1.82M	0.96%	26
2020 Q1	$53.7M	Sell	705,065 -1,021,180	-59%	-$87M	0.92%	33
2019 Q4	$153M	Buy	1,726,245 +6,895	+0.4%	+$572K	1.91%	6
2019 Q3	$130M	Buy	1,719,350 +238,535	+16%	+$16.4M	1.74%	11
2019 Q2	$108M	Buy	1,480,815 +404,500	+38%	+$31.8M	1.43%	16
2019 Q1	$86.7M	Buy	1,076,315 +13,865	+1%	+$1.13M	1.16%	18
2018 Q4	$97.9M	Buy	+1,062,450	New	+$93.4M	1.4%	14

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Vaughan Nelson Investment Management's ABBV Position: Q2 2026 in Review

Vaughan Nelson Investment Management held its AbbVie (ABBV) position steady in Q2 2026 at 8,635 shares worth $2.17M. The position accounts for 0.02% of the portfolio, ranked #160.

Vaughan Nelson Investment Management first reported a position in ABBV in Q4 2018 and has held it in 31 quarters since. The position peaked at $153M in Q4 2019. 2,841 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Vaughan Nelson Investment Management held 8,635 shares of AbbVie worth $2.17M as of Q2 2026.
Vaughan Nelson Investment Management left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.02% of Vaughan Nelson Investment Management's portfolio in Q2 2026, its #160 holding.
Vaughan Nelson Investment Management first reported a position in AbbVie in Q4 2018 and has held it in 31 quarters since.
Vaughan Nelson Investment Management's AbbVie position peaked at $153M in Q4 2019.
2,841 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Vaughan Nelson Investment Management's 13F filing for Q2 2026, filed 16 Jul 2026.